Clinical characteristics and in-hospital outcomes in patients aged 80 years or over with cardiac troponin-positive acute myocardial infarction -J-MINUET study.


Journal

Journal of cardiology
ISSN: 1876-4738
Titre abrégé: J Cardiol
Pays: Netherlands
ID NLM: 8804703

Informations de publication

Date de publication:
02 2021
Historique:
received: 13 05 2020
revised: 19 07 2020
accepted: 27 07 2020
pubmed: 18 9 2020
medline: 24 7 2021
entrez: 17 9 2020
Statut: ppublish

Résumé

The prevalence of acute myocardial infarction (AMI) in elderly people is increasing worldwide. However, their characteristics and prognosis have been rarely investigated. This study aimed to investigate the characteristics and prognosis in elderly patients with cardiac troponin-positive AMI. Consecutive patients with AMI from the J-MINUET study were divided into the following 3 groups: patients aged less than 65 years, those aged between 65 and 79 years, and those aged 80 years or over. Their characteristics and in-hospital outcomes were compared. Patients with AMI aged 80 years or over had the highest incidence of female gender, and the highest incidence of hypertension, chronic kidney disease, and cardiovascular disease, such as peripheral artery disease, atrial fibrillation, and stroke, whereas they had the lowest body mass index, and the lowest incidence of current smoker, diabetes mellitus, and dyslipidemia. Patients with AMI aged 80 years or over had significantly longer onset to door time and longer door to device time, and lower peak creatine kinase (CK). The incidence of ST-segment elevation myocardial infarction (STEMI) was the lowest in the AMI patients aged 80 years or over, but the patients had a higher incidence of in-hospital death and cardiac failure than the other two groups. In addition, the presentation with STEMI and non-ST-segment elevation myocardial infarction with CK elevation among patients aged 80 years or over showed the highest incidence of in-hospital death and cardiac failure. J-MINUET showed different clinical characteristics between the aged and younger populations. The incidence of in-hospital death and cardiac failure in patients aged 80 years or over with AMI was poorer than their younger counterparts.

Sections du résumé

BACKGROUND
The prevalence of acute myocardial infarction (AMI) in elderly people is increasing worldwide. However, their characteristics and prognosis have been rarely investigated. This study aimed to investigate the characteristics and prognosis in elderly patients with cardiac troponin-positive AMI.
METHODS
Consecutive patients with AMI from the J-MINUET study were divided into the following 3 groups: patients aged less than 65 years, those aged between 65 and 79 years, and those aged 80 years or over. Their characteristics and in-hospital outcomes were compared.
RESULTS
Patients with AMI aged 80 years or over had the highest incidence of female gender, and the highest incidence of hypertension, chronic kidney disease, and cardiovascular disease, such as peripheral artery disease, atrial fibrillation, and stroke, whereas they had the lowest body mass index, and the lowest incidence of current smoker, diabetes mellitus, and dyslipidemia. Patients with AMI aged 80 years or over had significantly longer onset to door time and longer door to device time, and lower peak creatine kinase (CK). The incidence of ST-segment elevation myocardial infarction (STEMI) was the lowest in the AMI patients aged 80 years or over, but the patients had a higher incidence of in-hospital death and cardiac failure than the other two groups. In addition, the presentation with STEMI and non-ST-segment elevation myocardial infarction with CK elevation among patients aged 80 years or over showed the highest incidence of in-hospital death and cardiac failure.
CONCLUSIONS
J-MINUET showed different clinical characteristics between the aged and younger populations. The incidence of in-hospital death and cardiac failure in patients aged 80 years or over with AMI was poorer than their younger counterparts.

Identifiants

pubmed: 32938566
pii: S0914-5087(20)30291-4
doi: 10.1016/j.jjcc.2020.08.006
pii:
doi:

Substances chimiques

Troponin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

139-146

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Auteurs

Tsunenari Soeda (T)

Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Japan. Electronic address: tsunenari0414@hotmail.com.

Hiroyuki Okura (H)

Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Japan; Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan.

Yoshihiko Saito (Y)

Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Japan.

Koichi Nakao (K)

Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center, Kumamoto, Japan.

Yukio Ozaki (Y)

Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan.

Kazuo Kimura (K)

Cardiovascular Center, Yokohama City University Medical Center, Yokohama, Japan.

Junya Ako (J)

Department of Cardiovascular Medicine, Kitasato University, Sagamihara, Japan.

Teruo Noguchi (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Satoru Suwa (S)

Department of Cardiology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.

Kazuteru Fujimoto (K)

Department of Cardiology, National Hospital Organization, Kumamoto Medical Center, Kumamoto, Japan.

Yasuharu Nakama (Y)

Department of Cardiology, Miyoshi Central Hospital, Miyoshi, Japan.

Takashi Morita (T)

Division of Cardiology, Osaka General Medical Center, Osaka, Japan.

Wataru Shimizu (W)

Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.

Atsushi Hirohata (A)

Department of Cardiovascular Medicine, The Sakakibara Heart Institute of Okayama, Okayama, Japan.

Yasuhiro Morita (Y)

Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.

Teruo Inoue (T)

Department of Cardiovascular Medicine, Dokkyo Medical University, Tochigi, Japan.

Atsunori Okamura (A)

Department of Cardiology, Sakurabashi Watanabe Hospital, Osaka, Japan.

Toshiaki Mano (T)

Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan.

Kazuhito Hirata (K)

Department of Cardiology, Okinawa Chubu Hospital, Uruma, Japan.

Kengo Tanabe (K)

Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan.

Yoshisato Shibata (Y)

Department of Cardiology, Miyazaki Medical Association Hospital, Miyazaki, Japan.

Mafumi Owa (M)

Department of Cardiovascular Medicine, Suwa Red Cross Hospital, Suwa, Japan.

Kenichi Tsujita (K)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Hiroshi Funayama (H)

Division of Cardiovascular Medicine, Saitama Medical Center Jichi Medical University, Saitama, Japan.

Nobuaki Kokubu (N)

Department of Cardiovascular, Renal and Medabolic Medicine, Sapporo Medical University, Sapporo, Japan.

Ken Kozuma (K)

Department of Cardiology, Teikyo University, Tokyo, Japan.

Shiro Uemura (S)

Department of Cardiology, Kawasaki Medical School, Kurashiki, Japan.

Tetsuya Toubaru (T)

Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.

Keijirou Saku (K)

Department of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan.

Shigeru Oshima (S)

Department of Cardiology, Gunma Prefectural Cardiovascular Center, Maebashi, Japan.

Yoshihiro Miyamoto (Y)

Department of Preventive Cardiology, National Cerebral and Cardiovascular Center, Suita, Japan.

Hisao Ogawa (H)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Masaharu Ishihara (M)

Department of Cardiovascular and Renal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH